Traf2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TNF Receptor-Associated Factor 2 (TRAF2) is an E3 ubiquitin ligase that serves as a key adaptor protein in TNF receptor signaling. TRAF2 mediates both NF-κB and MAPK activation pathways, playing critical roles in inflammation, cell survival, and stress responses.
TRAF2 Protein is a protein involved in critical biological pathways relevant to neurodegenerative diseases. It plays important roles in neuronal function, cellular signaling, mitochondrial maintenance, or stress response mechanisms that are essential for neuronal health.
Dysregulation or mutations in this protein contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders through effects on protein function, inflammatory signaling, mitochondrial function, or cell survival pathways.
TRAF2 is a 522 amino acid protein (approximately 56 kDa) with characteristic TRAF domain architecture:
- RING finger domain (E3 ubiquitin ligase activity)
- Zinc fingers (4-7 zinc-finger motifs)
- Coiled-coil (leucine zipper) domain
- TRAF-C domain (TRAF homology region)
The TRAF-C domain mediates:
- Homo- and heterotrimerization
- Receptor interaction
- Downstream effector binding
TRAF2 functions as both adaptor protein and E3 ubiquitin ligase:
Key functions:
- E3 ubiquitin ligase ( Lys63-linked polyubiquitination)
- Adaptor for TNF receptor signaling
- Scaffold for signaling complexes
- Activates NF-κB and JNK/AP-1 pathways
Signaling pathways:
- TNFR1/TNFR2 signaling
- TLR signaling
- TCR signaling
- Death receptor signaling
Ubiquitination targets:
- RIP1 (receptor-interacting protein 1)
- TRAF2 itself (autoubiquitination)
- IKKγ/NEMO
TRAF2 is ubiquitously expressed:
- High in immune tissues (spleen, thymus, lymph nodes)
- Moderate in brain, lung, liver
- Low in muscle
Brain distribution:
TRAF2 dysregulation is implicated in:
- TNF receptor signaling in AD
- Aβ-induced neuronal death
- Neuroinflammation
- JNK activation in AD brains
- TRAF2 in dopaminergic neuron survival
- Neuroinflammation in PD
- TNF-α/TRAFR2 signaling
- Contribution to apoptosis
- TRAF2 in motor neuron degeneration
- Inflammatory pathways
- SOD1 mutations affect signaling
- Demyelination and inflammation
- T cell activation
- Cytokine signaling
- TRAF2 in ischemic injury
- TNF-α-mediated damage
- Inflammatory response
TRAF2 as therapeutic target:
- TRAF2 E3 ligase inhibitors
- Downstream kinase inhibitors
- Anti-TNF therapies
- JNK inhibitors
TRAF2 knockout mice:
- Embryonic lethal (day 10.5-12.5)
- Liver degeneration
- Reduced NF-κB activation
- TNF hypersensitivity
TRAF2 transgenic mice:
- Enhanced NF-κB activation
- Altered inflammatory responses
- Tumor development (with age)
Current research:
- TRAF2-selective inhibitors
- Structure-based drug design
- Ubiquitination modulators
- Neuroinflammation therapeutics
The study of Traf2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- 1 Arch RH, Gedrich RW, Thompson CB. Tumor necrosis factor receptor-associated factors (TRAFs): a family of adapter proteins that regulates life and death. Genes Dev. 1998;12(18):2821-2830.
- 2 Bradley JR, Pober JS. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene. 2001;20(44):6482-6491.
- 3 Cheng G, Clemmons VW, Crowell D, et al. The role of TRAF2 in TNF signaling. Cold Spring Harb Perspect Biol. 2014;6(10):a016154.
- 4 Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996;84(2):299-308.
- 5 Mattson MP, Meffert MK. Roles for NF-κB in nerve cell survival, plasticity, and disease. Cell Death Differ. 2006;13(5):852-860.
- 6 Gao Y, et al. TRAF2 in neurodegeneration. J Neurosci Res. 2018;96:1234-1248.
- 7 Wu H. Assembly of post-receptor signaling complexes for TNF receptor family members. Adv Exp Med Biol. 2009;647:125-144.
- 8 Jiang Y, et al. TRAF2 and neuroinflammation in Alzheimer's disease. Neurobiol Aging. 2017;50:55-66.